biologics

Barriers such as cost and accessibility highlight the urgent need for equitable healthcare solutions to ensure widespread adoption…

The partnership will add to Jubilant Biosys' drug discovery and preclinical development capabilities in biologics and antibody…

Biocon Biologics' study identifies six policy recommendations to improve access to biosimilars in LMICs, addressing healthcare…

OneSource Pharma targets biologics and drug-device markets with end-to-end solutions and global expansion

Stoffregen will take responsibility for Enzene’s global biologics business and lead the final stages of work to commission the…

Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution

This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…

The funding round is led by Alkem Laboratories and new investors, Eight Roads Ventures and F-Prime Capital

According to GlobalData’s report, ‘Future of Pharma—Looking Ahead to 2022’, biologics are forecast to significantly overtake…

Under the terms of the agreement, Axantia will register, distribute and market biosimilar Pegfilgrastim drug product in certain…